26489

26489
FitzGerald JM, Bleecker ER, Nair P, et al. Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2016; 388(10056):2128–41. DOI: 10.1016/S0140-6736(16)31322-8. http://www.ncbi.nlm.nih.gov/pubmed/27609406
Einstellungen
26489
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 25.01.2021 | 18:45 Uhr